Get a glimpse into our company and investor data—powered by the PitchBook Platform
Owner and operator of a biopharmaceutical company. The company develops a class of mitochondrial-targeted antioxidants for the treatment of neurodegenerative diseases.
You’re viewing a free company profile from the PitchBook Platform. To explore Solano’s full profile, request a free trial.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.